232 related articles for article (PubMed ID: 15272577)
21. [Significance of tumor markers in the treatment of urological malignancies].
Akaza H; Kameyama S; Aso Y
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
[TBL] [Abstract][Full Text] [Related]
22. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
23. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
25. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
27. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.
Yates DR; Rouprêt M; Drouin SJ; Comperat E; Ricci S; Lacave R; Sèbe P; Cancel-Tassin G; Bitker MO; Cussenot O
Prostate; 2012 Sep; 72(12):1382-8. PubMed ID: 22228175
[TBL] [Abstract][Full Text] [Related]
28. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of seminoma patients with serum markers.
Hotakainen K; Lempiäinen A; Stenman UH
Cancer; 2013 Jul; 119(13):2511. PubMed ID: 23584987
[No Abstract] [Full Text] [Related]
30. Reply to Monitoring of seminoma patients with serum markers.
Vesprini D; Warde P; Chung P
Cancer; 2013 Jul; 119(13):2511-2. PubMed ID: 23584974
[No Abstract] [Full Text] [Related]
31. Tumor markers in advanced nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Nochomovitz LE; Goldmann A; Fraley EE; Rosai J; Johnson K; Kennedy BJ
Cancer; 1981 Feb; 47(3):572-6. PubMed ID: 6164464
[TBL] [Abstract][Full Text] [Related]
32. Urologic cancer in China.
Pang C; Guan Y; Li H; Chen W; Zhu G
Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic markers for human prostate cancer.
Gao X; Porter AT; Grignon DJ; Pontes JE; Honn KV
Prostate; 1997 Jun; 31(4):264-81. PubMed ID: 9180937
[TBL] [Abstract][Full Text] [Related]
34. Biological markers in urologic cancer.
Lange PH; Winfield HN
Cancer; 1987 Aug; 60(3 Suppl):464-72. PubMed ID: 3036331
[TBL] [Abstract][Full Text] [Related]
35. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology.
Liu N; Liang W; Ma X; Li X; Ning B; Cheng C; Ou G; Wang B; Zhang J; Gao Z
Biosens Bioelectron; 2013 Sep; 47():92-8. PubMed ID: 23567627
[TBL] [Abstract][Full Text] [Related]
37. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
38. Serotonin used as prognostic marker of urological tumors.
Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
40. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
